Cargando…
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
Alzheimer’s disease (AD) is a form of dementia characterized by progressive memory decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment strategies for AD are urgently needed. In this study, we found that microRNA-485-3p (miR-485-3p) was overexpressed in the brai...
Autores principales: | Koh, Han Seok, Lee, SangJoon, Lee, Hyo Jin, Min, Jae-Woong, Iwatsubo, Takeshi, Teunissen, Charlotte E., Cho, Hyun-Jeong, Ryu, Jin-Hyeob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658496/ https://www.ncbi.nlm.nih.gov/pubmed/34884940 http://dx.doi.org/10.3390/ijms222313136 |
Ejemplares similares
-
Correction: Koh et al. Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression. Int. J. Mol. Sci. 2021, 22, 13136
por: Koh, Han Seok, et al.
Publicado: (2022) -
Innate Immunity and Cell Death in Alzheimer's Disease
por: Lee, SangJoon, et al.
Publicado: (2021) -
Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021) -
miRNAs as Therapeutic Tools in Alzheimer’s Disease
por: Lee, Chang Youn, et al.
Publicado: (2021) -
MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2
por: Li, Jibin, et al.
Publicado: (2022)